Dr. Jonathan P. Terdiman, MD

Dr. Terdiman practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Terdiman's NPI, 1821040320, was assigned on May 16, 2006. Dr. Terdiman graduated from Vagelos College of Physicians and Surgeons in 1989. Dr. Terdiman holds California license G70554.

Dr. Terdiman's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Terdiman's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Terdiman to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Terdiman practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Terdiman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Terdiman is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Terdiman is licensed in California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Terdiman treats.

CMS data shows 653 Medicare services from Dr. Terdiman across 12 procedure codes in 2024, for 358 Medicare patients. Medicare paid $69,020 for them.

CMS counts 358 Medicare patients who saw Dr. Terdiman in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Terdiman's median patient age at 63, with 52% women.

In 2024, Dr. Terdiman wrote 455 Medicare Part D claims for 127 patients. 51% of them were for generic drugs. CMS names the drug for 294 of them, across 15 drugs with 11 or more claims each, at $1,590,954 in total drug cost. In 2023, CMS named 526 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Terdiman for performance year 2024, reported as part of a group. Dr. Terdiman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Terdiman as offering telehealth. CMS counts 101 procedures of colonoscopy by Dr. Terdiman, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 107 papers to Dr. Terdiman, published from 2004 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis and Crohn Disease. Dr. Terdiman has published most often in Gastroenterology. Dr. Terdiman's most frequent co-authors are Trilokesh Dey Kidambi, MD, Uma Mahadevan, MD and Frederic M. Waldman, MD.

CMS Open Payments shows 9 general payments to Dr. Terdiman from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pentax of America, Inc. paid the most, $76.

Dmand AI lists 4 awards for Dr. Terdiman, most recently Regional Top Doctor in 2014.

Dr. Terdiman graduated from Vagelos College of Physicians and Surgeons in 1989. Dr. Terdiman is a member of ACG.

Dr. Terdiman is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.